✦ LIBER ✦

The risks and the benefits of mesalazine as a treatment for ulcerative colitis

✍ Scribed by Moss, Alan C; Peppercorn, Mark A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Andrographis paniculata extract versus m

✍ R Guo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Recurrence of myocarditis after mesalazi

✍ Tony Sabatini; Alida Filippini; Francesca Nicosia; Stefania Preti; Maurizio Bert 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

Non-pathogenic Escherichia coli versus m

✍ BJ Rembacken; AM Snelling; PM Hawkey; DM Chalmers; ATR Axon 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 93 KB

Mesalazine versus olsalazine for prophyl

✍ RECORD, C 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 181 KB

Diet as a risk factor for the developmen

✍ B.J Geerling; P.C Dagnelie; A Badart-Smook; M.G Russel; R.W Stockbrügger; R.-J.M 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB

The cost-utility of high dose oral mesal

✍ A. BUCKLAND; K. BODGER 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB